These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37256725)

  • 1. IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing Cholangitis.
    Dold L; Frank L; Lutz P; Kaczmarek DJ; Krämer B; Nattermann J; Weismüller TJ; Branchi V; Toma M; Gonzalez-Carmona M; Strassburg CP; Spengler U; Langhans B
    Clin Transl Gastroenterol; 2023 Aug; 14(8):e00603. PubMed ID: 37256725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT activation in regulatory CD4
    Dold L; Kalthoff S; Frank L; Zhou T; Esser P; Lutz P; Strassburg CP; Spengler U; Langhans B
    Immun Inflamm Dis; 2024 Apr; 12(4):e1248. PubMed ID: 38607233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-374b-5p and miRNA-106a-5p are related to inflammatory bowel disease via regulating IL-10 and STAT3 signaling pathways.
    Li D; Liu L; Du X; Ma W; Zhang J; Piao W
    BMC Gastroenterol; 2022 Nov; 22(1):492. PubMed ID: 36437465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
    Lampinen M; Vessby J; Fredricsson A; Wanders A; Rorsman F; Carlson M
    J Crohns Colitis; 2019 Mar; 13(3):341-350. PubMed ID: 30383225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.
    Lafdil F; Wang H; Park O; Zhang W; Moritoki Y; Yin S; Fu XY; Gershwin ME; Lian ZX; Gao B
    Gastroenterology; 2009 Dec; 137(6):2125-35.e1-2. PubMed ID: 19686746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
    Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
    J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A.
    Lieshout R; Kamp EJCA; Verstegen MMA; Doukas M; Dinjens WNM; Köten K; IJzermans JNM; Bruno MJ; Peppelenbosch MP; van der Laan LJW; de Vries AC
    Int J Cancer; 2023 Jun; 152(12):2607-2614. PubMed ID: 36346104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
    Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.
    Kunkl M; Mastrogiovanni M; Porciello N; Caristi S; Monteleone E; Arcieri S; Tuosto L
    Front Immunol; 2019; 10():864. PubMed ID: 31068940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
    Andrews TS; Nakib D; Perciani CT; Ma XZ; Liu L; Winter E; Camat D; Chung SW; Lumanto P; Manuel J; Mangroo S; Hansen B; Arpinder B; Thoeni C; Sayed B; Feld J; Gehring A; Gulamhusein A; Hirschfield GM; Ricciuto A; Bader GD; McGilvray ID; MacParland S
    J Hepatol; 2024 May; 80(5):730-743. PubMed ID: 38199298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
    Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
    Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.
    De Simone V; Franzè E; Ronchetti G; Colantoni A; Fantini MC; Di Fusco D; Sica GS; Sileri P; MacDonald TT; Pallone F; Monteleone G; Stolfi C
    Oncogene; 2015 Jul; 34(27):3493-503. PubMed ID: 25174402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
    Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
    J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease.
    Carey R; Jurickova I; Ballard E; Bonkowski E; Han X; Xu H; Denson LA
    Inflamm Bowel Dis; 2008 Apr; 14(4):446-57. PubMed ID: 18069684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice.
    Yang W; Yao Y; Yang YQ; Lu FT; Li L; Wang YH; Nakajima T; Tsuneyama K; Ridgway WM; Gershwin ME; Lian ZX
    PLoS One; 2014; 9(8):e105351. PubMed ID: 25133396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.
    Zen Y; Fujii T; Harada K; Kawano M; Yamada K; Takahira M; Nakanuma Y
    Hepatology; 2007 Jun; 45(6):1538-46. PubMed ID: 17518371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
    Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
    J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
    Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase-1 directly binds STAT3 to control the generation of pathogenic Th17 cells during neutrophilic airway inflammation.
    Lin XL; Lv JJ; Lv J; Di CX; Zhang YJ; Zhou T; Liu JL; Xia ZW
    Allergy; 2017 Dec; 72(12):1972-1987. PubMed ID: 28580587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.